Author: The Free Press

Honestly presents Chapter 1 of The Witch Trails of J.K. Rowling

Host Megan Phelps-Roper writes a letter to J.K. Rowling—and receives a surprising invitation in reply: the opportunity for an intimate conversation in Rowling’s Scottish home.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Last month, Nikki Haley announced she is running for President. Haley is someone who has consistently proven doubters wrong: she was the first female governor of South Carolina, she has never lost a race, she’s self-made, and she survived as U.S. Ambassador to the United Nations during a turbulent, chaotic Trump White House without so much as a scrape.

For the latter, some see her as a savvy, smart player of politics. Others see her as having dodged an important question, as she allied herself with Trump enough to stay in his good graces, but also stayed away from him just enough to appease his critics.

Her position on Trump is just one of many challenges that Haley will have to face in the Republican primaries. The other big issue is that in a post-Trump political landscape, can Haley’s oldschool Republican worldview resonate with the base of the party, which is increasingly isolationist and populist? On the flip side, perhaps Haley can be a breath of fresh air for the Republican party: a normal candidate who – as the Midterms seemed to prove – voters are more than ready to support. 

On today’s show, a conversation with Nikki Haley about why she’s running for president, who the Haley constituency is, how she responds to her fiercest critics (Don Lemon, we’re looking at you), her vision for the future of the country, and why she thinks she has what it takes to be the next President of the United States. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

For the past two weeks, tens of thousands of people, most of them college students, poured into a small chapel at Asbury University in Wilmore, Kentucky. Some drove from South Carolina and Oklahoma. Others flew in from Canada and Singapore. They waited in line for hours to stand next to people they share nothing in common with except for a single conviction: God was visiting a two-stoplight town in Kentucky.

Religion has been on the decline in America for years. But last year, for the first time in American history, house-of-worship membership dropped below 50%. And nowhere is the decline in religion and faith more dramatic than when you look at our youngest generation. Gen Z is the most likely generation ever to say they don’t believe in God, and they are the least religiously affiliated and the least likely to attend church.

Zoomers are also a generation riddled with anxiety and depression, and inundated with nihilistic and fatalistic messages – TV shows, movies, pop songs – throughout the culture. In poll after poll, they are the generation with the least positive outlook on life. The CDC recently published a report stating that “almost 60% of female students experienced persistent feelings of sadness or hopelessness during the past year.”

And yet, in this tiny chapel in Kentucky, God, faith, meaning and hope have been on full display.

What moved so many young people to nonstop prayer – more than 250 hours – at a moment like this? How did this revival come to be? And why is it happening now? Today, Free Press reporter Olivia Reingold explains from the chapel at the Asbury Revival.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Ozempic, the brand name drug for a medication called semaglutide, is one of the most popular drugs on the market right now. Originally developed to treat type 2 diabetes, the injectable drug has recently boomed in popularity for its off-label use to help people lose weight... fast. Celebrities and public figures have admitted they're taking it. Instagram influencers are showing off remarkable before and after photos. It's been called "TikTok's favorite weight loss drug." As one doctor said, "we haven't seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market."

But alongside the rise in Ozempic prescriptions come many questions still unknown: Who should be taking it? Is it safe for longterm use? Who is it safe for? Should children be prescribed it to treat childhood obesity, as the American Academy of Pediatrics recently advised? Is Ozempic a permanent solution to the obesity epidemic? Or is it more like a bandaid, a quick fix that does little to address the root causes of obesity? And, to that end, what is the root cause of obesity? Is it a "brain disease," as one Harvard doctor recently declared on 60 Minutes that warrants medication? Or do diet, exercise, willpower and other behavioral lifestyle choices still matter?

These are questions that my guests do not agree on. Dr. Chika Anekwe is an obesity medicine physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School. Dr. Vinay Prasad is a hematologist-oncologist and a professor at the University of California San Francisco. His most recent book is Malignant: How Bad Policy and Bad Evidence Harm People with Cancer. And Calley Means is a former consultant for food and Pharma companies who now works to expose their practices and instead incentive healthy food as the foundation of health policy.

Today, Dr. Anekwe, Dr. Prasad, and Means debate: will Ozempic solve obesity in America?

Learn more about your ad choices. Visit megaphone.fm/adchoices